文献速递产科母胎医学

早产胎膜早破预防性抗凝决策分析

Prophylactic anticoagulation for preterm premature rupture of membranes: a decision analysis.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-01-22

本研究用决策分析Markov模型比较单胎妊娠孕24周后因早产胎膜早破住院至分娩者使用普通肝素、低分子肝素或不抗凝的结局。模型显示不预防性抗凝使母体效用最大化,Monte Carlo概率敏感性分析中不预防在56%模拟中为首选。结果不支持常规预防性抗凝。

要点

  • 不预防性抗凝在决策模型中使母体效用最大化
  • 概率敏感性分析中不预防在56%模拟中为首选
  • 结果不支持早产胎膜早破住院者常规预防性抗凝

核心结论

  • 不预防性抗凝在决策分析模型中使母体效用最大化,结果不支持对因早产胎膜早破住院的低危单胎妊娠常规使用预防性抗凝。

研究设计与样本

  • 构建TreeAge决策分析Markov模型,比较普通肝素、低分子肝素或不抗凝用于孕24周后因早产胎膜早破住院至分娩的单胎妊娠妇女。
  • 模型概率与效用来自现有文献,并进行敏感性分析和Monte Carlo概率敏感性分析。

主要发现

  • 在决策分析模型中,不预防性抗凝使母体效用最大化。
  • 理论队列100,000名妇女的临床结局见表(原文未给出具体数值)。
  • 单因素和双因素敏感性分析支持该结论。
  • Monte Carlo概率敏感性分析显示不预防在56%模拟中为首选,普通肝素为34%,低分子肝素为10%。

临床怎么用

  • 可为孕24周后因早产胎膜早破住院的低危单胎妊娠是否预防性抗凝提供决策参考,模型结果不支持常规使用。

局限性

  • 研究为决策分析模型,概率与效用来自现有文献而非直接临床研究。
  • 原文未报告模型的具体概率、效用值及理论队列的临床结局数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The current standard of care in the setting of preterm premature rupture of membranes involves antenatal hospitalization until delivery. The reduced physical activity during this time compounds the heightened risk for venous thromboembolism in pregnancy. Prophylactic anticoagulation can decrease this risk of venous thromboembolism; however, this benefit must be balanced against the risks of precluding neuraxial analgesia or increasing the risk of postpartum hemorrhage. OBJECTIVE: The objective of this study was to determine the optimal modality for venous thromboembolism prophylaxis during hospitalization for preterm premature rupture of membranes using a decision analysis model. STUDY DESIGN: A decision-analytical Markov model was constructed using the TreeAge software comparing the use of unfractionated heparin, low-molecular-weight heparin or no anticoagulation in women with a singleton pregnancy who were hospitalized for preterm premature rupture of membranes after 24 weeks and remained hospitalized until delivery. Maternal outcomes examined included attainment of neuraxial analgesia (vs no analgesia for vaginal delivery or general anesthesia for cesarean delivery), venous thromboembolism, postpartum hemorrhage, and maternal death. Probabilities and utilities were derived from existing literature. Sensitivity analyses were performed to interrogate model assumptions, and a Monte Carlo probabilistic sensitivity analysis was performed to examine the robustness of the model. RESULTS: In this decision-analytical model, no prophylactic anticoagulation maximized maternal utilities. Clinical outcomes among a theoretical cohort of 100,000 women are shown in the Table. The 1- and 2-way sensitivity analyses supported this conclusion. Monte Carlo probabilistic sensitivity analysis indicated that no prophylaxis was the preferred choice in 56% of simulations, unfractionated heparin in 34% of simulations, and low-molecular-weight heparin in 10% of simulations. CONCLUSION: Our results do not support the routine use of prophylactic anticoagulation in women admitted to the hospital for preterm premature rupture of membranes. These findings can be used to inform clinical decisions when admitting low-risk singleton pregnancies to the hospital in the setting of preterm premature rupture of membranes.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Iroz CB, Dahl CM, Cassimatis IR, et al. Prophylactic anticoagulation for preterm premature rupture of membranes: a decision analysis. Am J Obstet Gynecol MFM. 2021. PMID: 33493702. doi:10.1016/j.ajogmf.2021.100311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。